Global Artificial Organs and Bionic Implants Market Growth (Status and Outlook) 2023-2029

Global Artificial Organs and Bionic Implants Market Growth (Status and Outlook) 2023-2029

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.

LPI (LP Information)' newest research report, the “Artificial Organs and Bionic Implants Industry Forecast” looks at past sales and reviews total world Artificial Organs and Bionic Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Organs and Bionic Implants sales for 2023 through 2029. With Artificial Organs and Bionic Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Organs and Bionic Implants industry.

This Insight Report provides a comprehensive analysis of the global Artificial Organs and Bionic Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Organs and Bionic Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Organs and Bionic Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Organs and Bionic Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Organs and Bionic Implants.

The global Artificial Organs and Bionic Implants market size is projected to grow from US$ 8944.1 million in 2022 to US$ 15000 million in 2029; it is expected to grow at a CAGR of 7.7% from 2023 to 2029.

North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Organs and Bionic Implants market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others

Segmentation by application
Commercialize
Clinical Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics

Please note: The report will take approximately 2 business days to prepare and deliver.